Implementing Early Depression Screening as Routine Practice in Pharmacy Settings

This study examined the feasibility and impact of implementing routine depression screening in pharmacy settings through a 4-phase approach. A systematic literature review identified evidence supporting pharmacist-led screenings as effective and acceptable, with studies reporting improved detection rates and positive patient outcomes. Legislative analysis revealed strong international frameworks, particularly in the United States and United Kingdom, emphasizing pharmacists’ role in mental health care. A situational analysis in Bulgaria highlighted a significant unmet need, with high prevalence of depressive symptoms among chronically ill patients and limited access to mental health specialists. These findings underscore the potential of community pharmacies to bridge care gaps. Based on the evidence, key recommendations include developing pharmacist training programs, advocating for supportive legislation and funding, launching public awareness campaigns to reduce stigma, and establishing collaborative referral networks with other healthcare providers. Implementing these measures can facilitate early detection, timely intervention, and improved public health outcomes by leveraging the accessibility and expertise of pharmacists in mental healthcare.